Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,773.20
(
0.00%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
93.98
(
-1.09%
)
Bitcoin
77,855.36
(
2.00%
)
News Focus
News Focus
Post# of 257433
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 211022

Monday, 02/22/2021 9:44:45 AM

Monday, February 22, 2021 9:44:45 AM

Post# of 257433
AZN withdraws Imfinzi in bladder cancer after failure to show survival advantage in post-marketing study:

https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/voluntary-withdrawal-imfinzi-us-bladder-indication.html

The FDA gave Imfinzi accelerated approval in bladder cancer (its first approved indication) in 2017, based on ORR/DoR data in a phase-2 trial (#msg-130966037).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today